美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Principia Biopharma Inc.

100.05

0.0000

成交量：- -

成交額：- -

市值：33.28億

市盈率：-44.01

高：100.05

開：100.05

低：100.05

收：100.05

52周最高：101.89

52周最低：25.35

股本：3,325.99萬

流通股本：2,304.04萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2732

每股收益(LYR):-2.0867

淨資產收益率：-26.40%

總資產收益率：-16.03%

市淨率：9.47

市盈率(LYR):-47.95

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Principia Biopharma Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.principiabio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Principia Biopharma Inc.於2008年10月6日在特拉華州註冊成立，於2011年2月開始運營，總部位於加利福尼亞州南舊金山。該公司是一家臨床階段的生物製藥公司，致力於開發免疫學和腫瘤學的新療法。他們專有的Tailored Covalency平台使他們能夠設計和開發可逆的共價和不可逆的共價小分子抑製劑，其效力和選擇性可以與可注射的生物製劑相媲美，同時保持藥丸的便利性。Principia Biopharma已經從他們的平台生產了三種新的候選藥物，在其運作的前七年中產生了四種臨床計劃。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PRNB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNB\",,,,,undefined,":{"symbol":"PRNB","market":"US","secType":"STK","nameCN":"Principia Biopharma Inc.","latestPrice":100.05,"timestamp":1601064000000,"preClose":100.05,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":23040425,"shares":33259922,"eps":-2.27321,"marketStatus":"停牌","change":0,"latestTime":"09-25 16:00:00 EDT","open":100.05,"high":100.05,"low":100.05,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.27321,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1536897600000,"exchange":"NASDAQ","adjPreClose":100.05,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNB\",,,,,undefined,":{"symbol":"PRNB","floatShares":23040425,"roa":"-16.03%","roe":"-26.40%","lyrEps":-2.08673,"shares":33259922,"dividePrice":0,"high":100.05,"amplitude":0,"preClose":100.05,"low":100.05,"week52Low":25.35,"pbRate":"9.47","week52High":101.89,"institutionHeld":0,"latestPrice":100.05,"eps":-2.27321,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.27321,"open":100.05,"prevYearClose":54.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-09-29","symbol":"PRNB","reason":null,"defaultRemindTime":1601386200000,"announcedDate":"2020-09-22","type":"delisting","dateTimestamp":1601352000000},{"market":"US","date":"2020-08-06","symbol":"PRNB","fiscalQuarterEnding":"2020/06","expectedEps":-0.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":0.31},{"market":"US","date":"2020-05-06","symbol":"PRNB","fiscalQuarterEnding":"2020/03","expectedEps":-0.79,"name":null,"time":"","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"","actualEps":-0.99},{"market":"US","date":"2020-03-10","symbol":"PRNB","fiscalQuarterEnding":"2019/12","expectedEps":-0.78,"name":null,"time":"盤後","type":"earning","dateTimestamp":1583812800000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2019-11-05","symbol":"PRNB","fiscalQuarterEnding":"2019/09","expectedEps":-0.85,"name":null,"time":"","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRNB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRNB","date":"2020-09-25","current":-44.012652,"percent":0.462338,"low":-124.629826,"twenty":-107.219667,"median":-47.266471,"eighty":-29.279962,"high":123.127587,"avg":-27.017627,"sd":57.598869,"marketCap":3324329203},"quantilePoints":[],"updateTime":1779252041368},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.principiabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Principia Biopharma Inc.於2008年10月6日在特拉華州註冊成立，於2011年2月開始運營，總部位於加利福尼亞州南舊金山。該公司是一家臨床階段的生物製藥公司，致力於開發免疫學和腫瘤學的新療法。他們專有的Tailored Covalency平台使他們能夠設計和開發可逆的共價和不可逆的共價小分子抑製劑，其效力和選擇性可以與可注射的生物製劑相媲美，同時保持藥丸的便利性。Principia Biopharma已經從他們的平台生產了三種新的候選藥物，在其運作的前七年中產生了四種臨床計劃。","exchange":"NASDAQ","name":"Principia Biopharma Inc.","nameEN":"Principia Biopharma Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRNB\",market:\"US\",,,undefined,":null}}